These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35446199)

  • 21. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression.
    Li W; Yang D; Zhang Y; Zhao S; Li D; Liu M
    Oncol Rep; 2020 Nov; 44(5):1985-1996. PubMed ID: 33000253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA NBAT1 suppresses cell proliferation and migration via miR-346/GSK-3β axis in renal carcinoma.
    Xue S; Wang S; Li J; Guan H; Jiang S; Guo Y; Li Q
    IUBMB Life; 2019 Nov; 71(11):1720-1728. PubMed ID: 31298469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p.
    Sun Y; Tian Y; He J; Tian Y; Zhang G; Zhao R; Zhu WJ; Gao P
    Cell Death Dis; 2022 Jan; 13(1):51. PubMed ID: 35017464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR-203 and promoting the expression of BIRC5.
    Zhang H; Li W; Gu W; Yan Y; Yao X; Zheng J
    Cell Prolif; 2019 Sep; 52(5):e12640. PubMed ID: 31250518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0008717 promotes renal cell carcinoma progression by upregulating FBXO17 via targeting miR-217.
    Shen S; Jiang M; Deng W; Liu X; Xiong J; Zeng Z; Zhao H; Zeng X; Fu B
    J Gene Med; 2022 Nov; 24(11):e3418. PubMed ID: 35357059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5.
    Zhang L; Wang C; Ma M
    Kidney Blood Press Res; 2021; 46(5):613-619. PubMed ID: 34352801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
    Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
    J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma.
    Zeng HF; Qiu HY; Feng FB
    Oncol Res; 2018 Apr; 26(3):335-343. PubMed ID: 28390115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
    Wang D; Zhu X; Siqin B; Ren C; Yi F
    Toxicol Appl Pharmacol; 2022 Jul; 447():116067. PubMed ID: 35597301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.
    Li J; Huang C; Zou Y; Ye J; Yu J; Gui Y
    Mol Cancer; 2020 Jun; 19(1):103. PubMed ID: 32503552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-506 pathway.
    Zhang C; Hu Z; Fu Y; Wang J
    Aging (Albany NY); 2024 Jun; 16(13):10832-10840. PubMed ID: 38968431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
    Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
    Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Noncoding RNA LINC01133 Confers Tumor-Suppressive Functions in Ovarian Cancer by Regulating Leucine-Rich Repeat Kinase 2 as an miR-205 Sponge.
    Liu M; Shen C; Wang C
    Am J Pathol; 2019 Nov; 189(11):2323-2339. PubMed ID: 31640854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
    Tao M; Zhou Y; Jin Y; Pu J
    Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA 00312 Attenuates Cell Proliferation and Invasion and Promotes Apoptosis in Renal Cell Carcinoma via miR-34a-5p/ASS1 Axis.
    Zeng J; Li Y; Wang Y; Xie G; Feng Q; Yang Y; Feng J
    Oxid Med Cell Longev; 2020; 2020():5737289. PubMed ID: 32308805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
    J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
    Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
    Huang X; Gao Y; Qin J; Lu S
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.